Results 71 to 80 of about 11,035 (153)
, 2020 Maheta S et al 351 ABSTRACT: A new, simple, precise, accurate and sensitive High Performance Thin Layer Chromatographic method has been developed for the estimation of Timolol Maleate and Brimonidine Tartrate in bulk and marketed ophthalmic formulation ...
Ms Suketa Maheta
core
Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
International Journal of Ophthalmology, 2013 AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or ...
Jeanette A. Stewart +6 more
doaj +1 more source
Current Directions in Biomedical Engineering, 2018 Glaucoma is the second most common cause of blindness. An increased intraocular pressure is the only treatable symptom of glaucoma. Because patients often exhibit a poor therapy adherence, a drug depot consisting of ELA-NCO and hyaluronic acid with ...
Eickner Thomas +7 more
doaj +1 more source
Case Reports in Critical Care, 2015 Timolol Maleate (also called Timolol) is a nonselective beta-adrenergic blocker and a class II antiarrhythmic drug, which is used to treat intraocular hypertension.
Muhammad Asim Rana +6 more
doaj +1 more source
Symptomatic Bradycardia and Syncope due to Ophthalmic Timolol Maleate
Çukurova Üniversitesi Tıp Fakültesi Dergisi, 2014 Timolol maleate is a non-selective (effective to and szlig;1 and and szlig;2 receptors) is a topical beta blocker drug which is used in the treatment of glaucoma. Besides its topical impact, it may have some systemic side effects.
Muge Gulen +4 more
doaj
Complete atrioventricular block due to timolol eye drops: a case report and literature review
BMC Pharmacology and Toxicology, 2019 Background Timolol Maleate is a non-selective beta-adrenergic blocker that is commonly used to treat open-angle glaucoma. Despite its topical administration, ophthalmic timolol enters systemic circulation and produces a systemic beta-adrenergic blockade.
Zhuoying Wang +7 more
doaj +1 more source
Tolosa-Hunt syndrome after chikungunya infection [PDF]
Revista Brasileira de OftalmologiaThis case report aimed to describe the Tolosa-Hunt syndrome in a patient infected with chikungunya and highlight the relevance of considering chikungunya as a possible cause of the Tolosa-Hunt syndrome, especially in endemic or epidemic infection sites ...
Celso Busnelo Moreno +5 more
doaj +1 more source
, 2012 Purpose: Timolol maleate, the ophthalmic solutions, is frequently prescribed for glaucoma, although the use of this drop is likely to interfere with wound healing in corneal surgeries.
S, Mushtaq +2 more
core
Formulation, Development and Evaluation of Timolol Maleate Sustained Release Matrix Tablets [PDF]
, 2012 The present work is aimed at preparing and evaluating sustained-release (SR) matrix tablets of timolol maleate (TM) using different polymers. To study the effect of nature (hydrophilic and hydrophobic) of the polymer and drug: polymer ratio (1:0.5, 1 ...
Harinath, Boddu
core
Timolol Maleate Microspheres: An Ingenious Carrier for Sustained Release Antihypertensive Formulation [PDF]
Background: Timolol maleate is classified as a BCS Class I drug and functions as a non-selective β-adrenergic receptor blocker. Its ability to lower heart rate and cardiac output has led to its widespread use in the treatment of hypertension.
Solanki, Dipti +4 more
core +1 more source